Moritaka Goto
Miemachi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pharmacological profile of upacicalcet, a novel positive allosteric modulator of calcium-sensing receptor, in vitro and in vivo.
Journal: European journal of pharmacology
Published: March 31, 2022
Upacicalcet Is a Novel Secondary Hyperparathyroidism Drug that Targets the Amino Acid Binding Site of Calcium-Sensing Receptor .
Journal: Molecular pharmacology
Published: February 18, 2022
Pseudo-hyperglucagonemia was observed in pancreatectomized patients when measured by glucagon sandwich enzyme-linked immunosorbent assay.
Journal: Journal of diabetes investigation
Published: April 16, 2020
The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice.
Journal: Metabolism open
Published: November 03, 2019
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Journal: Scientific reports
Published: September 18, 2019
Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521].
Journal: European journal of pharmacology
Published: September 15, 2019
Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice.
Journal: European journal of pharmacology
Published: April 25, 2019
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis.
Journal: Leukemia
Published: February 13, 2019
Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Journal: Cellular and molecular gastroenterology and hepatology
Published: February 21, 2018
Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport.
Journal: Journal of diabetes investigation
Published: December 19, 2017
Last Updated: 09/26/2026